Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06064019

Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

Led by SciBase AB · Updated on 2024-12-11

150

Participants Needed

1

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective study to assess efficacy of the Nevisense device in identifying keratinocyte skin cancer (KC) in patients suspected of having skin cancer based on the initial physician's assessment. All skin lesions with a suspicion of Basal cell carcinoma (BCC), Invasive Squamos cell Carcinoma (iSCC), Bowen's disease (BD) or actinic keratosis (AK) and destined for excision or biopsy for further histopathological analysis will be considered for inclusion in the study.

CONDITIONS

Official Title

Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients of any ethnicity aged 18 years or older
  • Presence of skin lesions with uncertain diagnosis suspicious for keratinocyte skin cancer such as basal cell carcinoma, invasive squamous cell carcinoma, Bowen's disease, or actinic keratosis
  • Lesions planned for excision or biopsy for histopathological analysis
Not Eligible

You will not qualify if you...

  • Metastases of recurrent lesions
  • Lesions located on acral skin such as sole or palm
  • Lesions on areas of scars, crusts, psoriasis, or similar skin conditions
  • Lesions on hair-covered areas like scalp, beard, or moustache
  • Lesions located on genitalia
  • Lesions previously biopsied, surgically treated, or traumatized
  • Lesions on mucosal surfaces
  • Lesions with foreign matter such as tattoos or splinters
  • Lesions on or near acute sunburn
  • Lesions on skin surfaces that are not measurable such as those on stalks
  • Lesions on skin surfaces that are not accessible such as inside ears or under nails

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CentroDerm

Wuppertal, Germany

Actively Recruiting

Loading map...

Research Team

P

Per Svedenhag

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here